.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The COMPARE randomized trial directly compared two trabecular MIGS approaches—Hydrus and two iStent Trabecular Micro-Bypass devices—as standalone procedures in open-angle glaucoma. At 12 months, the Hydrus group had a higher proportion of eyes meeting the study's complete surgical-success definition and used fewer glaucoma medications. Secondary glaucoma surgery occurred in some iStent-treated eyes and none of the Hydrus eyes, while safety profiles were broadly similar. The study is useful because it compares devices rather than simply comparing MIGS with no surgery. For HCPs, the message is that MIGS devices are not interchangeable. Their mechanism, implant geometry, target anatomy and expected pressure-lowering range differ, and evidence for one platform should not automatically be extrapolated to another. The trial also studied a selected population with open angles and relatively good baseline vision, so the results should not be extended to advanced glaucoma requiring very low target pressures. For AIOC's MIGS theme, the paper provides a practical framework for discussing device selection and realistic expectations.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The COMPARE randomized trial directly compared two trabecular MIGS approaches—Hydrus and two iStent Trabecular Micro-Bypass devices—as standalone procedures in open-angle glaucoma. At 12 months, the Hydrus group had a higher proportion of eyes meeting the study's complete surgical-success definition and used fewer glaucoma medications. Secondary glaucoma surgery occurred in some iStent-treated eyes and none of the Hydrus eyes, while safety profiles were broadly similar. The study is useful because it compares devices rather than simply comparing MIGS with no surgery. For HCPs, the message is that MIGS devices are not interchangeable. Their mechanism, implant geometry, target anatomy and expected pressure-lowering range differ, and evidence for one platform should not automatically be extrapolated to another. The trial also studied a selected population with open angles and relatively good baseline vision, so the results should not be extended to advanced glaucoma requiring very low target pressures. For AIOC's MIGS theme, the paper provides a practical framework for discussing device selection and realistic expectations.
last month
A study demonstrates an explainable machine learning framework integrating clinical and echocardiographic metrics to predict left atrial appendage thrombus in non-valvular atrial fibrillation, utilizing SHAP analysis for clinical interpretability.
4 days back
A systematic review and transcriptomic cross-study consensus analysis illuminates the role of necroptosis in cervical cancer. By promoting anti-tumor immunogenicity and resolving apoptosis resistance, necroptotic pathways offer actionable prognostic signatures and promising avenues for combination immunotherapy.
2 days back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
Last week
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
